Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer.

Chang EY, Smith CA, Corless CL, Thomas CR Jr, Hunter JG, Jobe BA.

Am J Surg. 2007 May;193(5):614-7; discussion 617.

PMID:
17434367
2.

Biomarkers of response to preoperative chemoradiation in esophageal cancers.

Luthra R, Luthra MG, Izzo J, Wu TT, Lopez-Alvarez E, Malhotra U, Choi IS, Zhang L, Ajani JA.

Semin Oncol. 2006 Dec;33(6 Suppl 11):S2-5. Review.

PMID:
17178277
3.

Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal.

Visser BC, Venook AP, Patti MG.

Surg Oncol. 2003 Jul;12(1):1-7. Review.

PMID:
12689665
4.

Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues.

Chang F, Deere H, Mahadeva U, George S.

Am J Clin Pathol. 2008 Feb;129(2):252-62. doi: 10.1309/CCR3QN4874YJDJJ7. Review.

5.

[Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].

Fuchs HF, Hölscher AH.

Zentralbl Chir. 2014 Feb;139(1):32-6. doi: 10.1055/s-0033-1360295. Epub 2014 Feb 28. Review. German.

PMID:
24585195
6.

Section II: pathology and pathologic staging of esophageal cancer.

Glickman JN.

Semin Thorac Cardiovasc Surg. 2003 Apr;15(2):167-79. Review.

PMID:
12838487
7.

New therapeutic strategies for squamous cell cancer and adenocarcinoma.

Wijnhoven BP, Toxopeus EL, Vallböhmer D, Knoefel WT, Krasna MJ, Perez K, van Rossum PS, Ruurda JP, van Hillegersberg R, Schiesser M, Schneider P, Felix VN.

Ann N Y Acad Sci. 2013 Oct;1300:213-25. doi: 10.1111/nyas.12247. Review.

PMID:
24117644
8.

Treatment of Barrett's esophagus with high-grade dysplasia.

McAllaster JD, Buckles D, Al-Kasspooles M.

Expert Rev Anticancer Ther. 2009 Mar;9(3):303-16. doi: 10.1586/14737140.9.3.303. Review.

PMID:
19275509
9.

Treatment of locally advanced esophageal cancer with surgery and chemoradiation.

Siersema PD, van Hillegersberg R.

Curr Opin Gastroenterol. 2008 Jul;24(4):535-40. doi: 10.1097/MOG.0b013e3283025ca2. Review.

PMID:
18622172
10.

Combined modality therapy of esophageal cancer.

Juergens RA, Forastiere A.

J Natl Compr Canc Netw. 2008 Oct;6(9):851-60; quiz 861. Review.

PMID:
18926094
11.

Primary oesophageal carcinoma in teens.

Kumar A, Shukla NK, Mishra MC, Shahi UP, Kapur BM.

J Surg Oncol. 1992 Aug;50(4):254-7. Review.

PMID:
1640711
12.

Quantifying the benefit of a pathologic complete response after neoadjuvant chemoradiotherapy in the treatment of esophageal cancer.

Scheer RV, Fakiris AJ, Johnstone PA.

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):996-1001. doi: 10.1016/j.ijrobp.2010.03.003. Epub 2010 Jun 30. Review.

PMID:
20584580
13.

Esophagogastric cancer--time to change the paradigm.

O'Sullivan GC, Shanahan F.

Am J Gastroenterol. 2000 Sep;95(9):2153-4. Review. No abstract available.

PMID:
11007209
14.

Is neoadjuvant therapy the answer to adenocarcinoma of the esophagus?

Burak WE Jr.

Am J Surg. 2003 Sep;186(3):296-300. Review.

PMID:
12946836
15.

Anal cancer: current and future methodology.

Eng C.

Cancer Invest. 2006 Aug-Sep;24(5):535-44. Review.

PMID:
16939964
16.

Today's approach to esophageal cancer. What is the role of the primary care physician?

Fox JR, Kuwada SK.

Postgrad Med. 2000 May 1;107(5):109-14. Review.

PMID:
10844946
17.

Definitive chemoradiation in the management of locally advanced esophageal cancer.

Suntharalingam M.

Semin Radiat Oncol. 2007 Jan;17(1):22-8. Review.

PMID:
17185194
18.

Curing patients with locally advanced esophageal cancer: an update on multimodality therapy.

McKian KP, Miller RC, Cassivi SD, Jatoi A.

Dis Esophagus. 2006;19(6):448-53. Review.

PMID:
17069587
19.

Chemoradiation for gastrointestinal cancer.

Rich TA.

Front Radiat Ther Oncol. 1992;26:115-30. Review. No abstract available.

PMID:
1511913
Items per page

Supplemental Content

Write to the Help Desk